Keyword: immunology


US Merck Snaps up Prometheus Biosciences for $10.8 Billion

19.04.2023 -

Shares of Prometheus Biosciences soared on news that US drugs major Merck will acquire the company in an all-cash deal valued at roughly $200 per share, or $10.8 billion...


Bayer Plans to Scale Back Women’s Health R&D

27.03.2023 -

Ahead of a change in leadership at the top after the upcoming annual general meeting, in interviews with news agencies Bayer is dropping hints in dribbles about future...


Pfizer Doubles Dublin Biologicals Capacity

06.12.2022 -

Pfizer has announced plans to invest more than €1.2 billion at its site in Grange Castle, Dublin, Ireland, to double capacity for biological drug substances.


Sanofi and Ablynx Link on Nanobody Therapeutics

04.08.2017 - French drugmaker Sanofi has signed a research and licensing deal with Belgian biopharmaceutical company Ablynx, initially focusing on the development and commercialization of...

Plant Construction & Process Technology

The Possibilities Of Peptides

08.09.2016 - Peptides in pharmaceutical development have traveled a rough road. It took a long time for these small proteins to emerge as a basis for new medical products. This has become...


Novartis Splits Pharmaceutical Division

19.05.2016 - Swiss drugmaker Novartis has announced plans to split its Pharmaceutical division into two business units, Novartis Pharmaceutical and Novartis Oncology. The first-mentioned will...


Sanofi Appoints Dr. Yong-Jun Liu as Head of Global Research

29.03.2016 - French drug maker Sanofi has appointed Dr. Yong-Jun Liu, one of the world's most prolific researchers in immunology, as Head of Research, Global R&D, effective April 1, 2016. Dr...


AbbVie and Boehringer Collaborate on Immunology Drugs

09.03.2016 - US drug maker AbbVie and Germany’s Boehringer Ingelheim are collaborating to develop and commercialize BI 655066, a potential treatment for psoriasis. The drug is also being...